Radisens announces Medical Advisory Board

Cork – Nov 12, 2021 – Radisens, a developer of a rapid test to measure iron stores (ferritin), today announced the formation of its Medical Advisory Board (MAB) comprising clinical experts in obstetrics and gynaecology, patient blood management, paediatrics, haematology, heavy menstrual bleeding and global health. This group of world-renowned leaders within their respective medical fields provides the Company with important insights and clinical expertise as it continues to refine its strategy and advance through the product development phase.

Chairing the MAB is Richard J. Derman MD, MPH, FACOG who has served in academic leadership positions at four leading US institutions. He is the associate provost for global affairs, professor of obstetrics and gynecology, and director of global research at Thomas Jefferson University, Philadelphia. Dr. Derman’s commitment to global health evolved into having achieved positions as president, CEO, or senior consultant in the broad areas of medical communication, drug and technology development, not-for-profit global granting organizations, and currently as an academic leader in global health research. His work in addressing the leading causes of maternal and neonatal/infant mortality and morbidity in low and middle-income countries has been widely recognized. Dr. Derman’s recent research and subsequent publications have proven instrumental in scaling up global initiatives for clinical conditions such as postpartum hemorrhage, iron deficiency anemia, and the prevention of preterm birth. 

Other esteemed members of Radisens’ MAB include:

• Aryeh Shander, MD, FCCM, FCCP, FASA is Emeritus Chair, Department of Anesthesiology, Critical Care Medicine, Pain Management and Hyperbaric Medicine at Englewood Hospital & Medical Center in Englewood, NJ. He is Adjunct Clinical Professor, Department of Anesthesiology, Medicine and Surgery at Icahn School of Medicine at Mount Sinai as well as Clinical Professor of Anesthesiology at Rutgers New Jersey Medical School in NJ. He served as the Executive Medical Director of The Institute for Patient Blood Management and Bloodless Medicine and Surgery at Englewood Hospital, and Past-President of the Society for the Advancement of Patient Blood Management. Dr. Shander’s more than 200 peer reviewed publications have appeared in several prestigious peer-reviewed medical journals.

• Carlo Brugnara, MD a Professor of Pathology at Harvard Medical School and Director of the Haematology Laboratory at Boston Children’s Hospital, Boston. Dr. Brugnara is a fellow of the American Society of Clinical Investigation, the Association of American Physicians and the Academy of Clinical Laboratory Physicians and Scientists. Since 2007 he is the Editor-in-Chief of the American Journal of Hematology. Dr. Brugnara’s clinical laboratory-based research has been focused on the use of hematological parameters to assess the balance between iron availability and erythropoiesis.

• Malcolm Munro, MD, FRCSC, FACOG is a Clinical Professor in the Department of Obstetrics and Gynecology of the David Geffen School of Medicine at UCLA, Chair of the FIGO Menstrual Disorders Committee, Co-Chair of the SEUD Abnormal Uterine Bleeding (AUB) Task Force and Section Head of “Faculty Opinions” for Menstrual Disorders and Abnormal Uterine Bleeding. He is also a co-founder of the Women’s Health Research Collaborative that is dedicated to raising awareness of the relationship of the symptom of heavy menstrual bleeding (HMB) and iron deficiency through advocacy and “real world” evidence. His work has focused on the diagnosis and treatment of the various causes of AUB and the related disorders of iron deficiency and iron deficiency anemia frequently associated with one of the AUB symptoms, HMB.

At the same time, the following medical experts have joined as company mentors to guide on clinical and medical affairs:

• Michael Auerbach, MD, FACP, is a hematologist/oncologist at Auerbach Hematology and Oncology Associates, Inc., in Baltimore, Maryland, and a Clinical Professor of Medicine at Georgetown University School of Medicine in Washington DC. Dr. Auerbach has authored or coauthored over 190 journal articles, books, chapters and meeting abstracts, most recently focusing on intravenous iron supplementation in pregnancy, in patients with RLS and bariatric surgery. He is an author of the Treatment of Iron Deficiency in Adults, Anemia in Pregnancy, and Diagnosis and Causes of Iron Deficiency for UpToDate. He currently serves on the scientific board of the Network for Advancement of Transfusion Alternatives, advises the Society for the Advancement of Blood Management and is on the Editorial Boards of the American Journal of Hematology, Expert Review of Hematology and the American Journal of Medicine.

• Michael K. Georgieff, MD, holds the position of the Martin Lenz Harrison Land Grant Chair in Pediatrics at the University of Minnesota Medical School. He is a Professor of Pediatrics and Developmental Psychology, the Executive Vice Chair of the Department of Pediatrics, and the Director of the Center for Neurobehavioral Development. In addition to attending on the Neonatal Intensive Care Unit, Dr. Georgieff is Director of the NICU Follow-up Program. Dr. Georgieff’s research focuses on fetal/neonatal nutrition and brain development, specifically on the effect of early life iron nutrition and neurocognitive function. He has been continuously funded in this field by the National Institutes of Health for 30 years and has published over 250 scientific articles. He advises the American Academy of Pediatrics, the National Institutes of Health and UNICEF on nutrition and early child development.

Jerry O’Brien, Radisens CEO said “We are honoured to have such an esteemed group of clinical experts with over 200 years’ experience and several hundred publications in the field of iron deficiency. I very much appreciate their commitment in contributing their guidance, expertise and vision as the Company continues through product development and refines the medical use cases for iron deficiency screening”